Microfluidics device to detect cancer cells in blood
A recently developed microfluidics device is able to detect and separate out cancer cells in blood, without the need for dilution...
List view / Grid view
A recently developed microfluidics device is able to detect and separate out cancer cells in blood, without the need for dilution...
Bispecific T-cell engager technology (BiTE) could be used to quickly and accurately diagnose patients suffering from lung cancer...
An assay assessing the level of programmed death ligand 1 (PD-L1) could help to determine the method of treatment for lung cancer patients...
Researchers have identified how they can differentiate between lesions in the airways that are benign and those that could become cancerous...
A recently discovered enzyme could lead to the development of a treatment where cancer cells are starved of 'food' provided by this protein...
Brazilian researchers have discovered that a drug widely used as for chemotherapy also acts as an immune response modulator...
Tumour microenvironments give insights into more effective therapies against lung cancer, a bigger killer than colon, prostrate and breast cancers combined...
Researchers have developed a PET imaging method suitable for many forms of cancer, with high contrast and less inconvenience to patients...
Computer engineers have 'taught' a computer to identify tiny specs of lung cancer in CT scan images, often missed by radiologists...
Researchers have identified a gene that when inhibited, reduced human non-small cell lung cancer tumours from growing...
Scientists in the U.S. have found that human lung cancer cells resist dying by controlling parts of the ageing process. The discovery could help us better understand ageing and eventually lead to new treatments for cancer.
High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer.
Scientists in Japan have discovered a promising new biomarker – cytoskeleton-associated protein 4 (CKAP4) – for lung cancer, potentially transforming the way the disease is diagnosed and treated.
Doctors may soon be able to predict the efficacy of a widely used lung cancer drug based on an imaging agent and a simple scan.
Scientists have used molecular simulations to understand the resistance to osimertinib - an anticancer drug used to treat types of lung cancer...